Serum total homocysteine concentrations in adolescent and adult Americans: Results from the third National Health and Nutrition Examination Survey

American Journal of Clinical Nutrition

Volumn 69, Issue 3, 1999, Pages 482-489

  Jacques, Paul F ^a   Rosenberg, Irwin H ^b   Rogers, Gail ^b   Selhub, Jacob ^b   Bowman, Barbara A ^b   Gunter, Elaine W ^b   Wright, Jacqueline D ^b   Johnson, Clifford L ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

Adolescents; Adults; Age; Ethnic groups; Homocysteine concentrations; NHANES III; Nutrition surveys; Occlusive vascular disease; Race; Sex; Third National Health and Nutrition Examination Survey

Indexed keywords

HOMOCYSTEINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; DIET RESTRICTION; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

EID: 0033004216     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.3.482     Document Type: Article

References (40)

1. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis RBJ, ed. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, Inc. 1992:183-236.
2. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
3. Arnesen E, Refsum H, Bonna KH, Ueland PM, Forde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24:704-9.
4. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346: 1395-8.
5. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Serum total homocysteine and coronary heart disease in middle-aged British men. Heart 1996;75(suppl 1):P53 (abstr).
6. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation 1993;87:1107-13.
7. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
8. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
9. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-57.
10. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in the elderly. JAMA 1993;270:2693-8.
11. Nygard O, Vollset SE, Refsum H, et al. Plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526-33.
12. Brattström L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236:633-41.
13. Koehler KM, Romero LJ, Stauber PM, Pareo-Tubbeh SL, Liang HC. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 1996;15:364-76.
14. Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79-87.
15. Wouters MG, Moorrees MT, van der Mooren MJ, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25: 801-5.
16. van der Mooren MJ, Wouters MGAJ, Blom HJ, Schellekens LA, Eskes TKAB, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994;24:733-6.
17. Brattström LE, Israelsson B, Jeppsson J-O, Hultberg BL. Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988;48:215-21.
18. Wilcken DEL, Dudman NPB, Tyrrell PA. Robertson MR. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 1988;37:697-701.
19. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
20. Lindgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattström L. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med 1995;237:381-8.
21. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
22. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33.
23. National Center for Health Statistics, Centers for Disease Control and Prevention. Plan and operation of the third National Health and Nutrition Examination Survey, 1988-94. Washington, DC: US Government Printing Office, 1994. [Series 1,32. DHHS publication (PHS) 94 1308.]
24. National Center for Health Statistics. The third National Health and Nutrition Examination Survey (NHANES III, 1988-94): reference manuals and reports. Weighting and estimation methodology report [CD-ROM]. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 1996.
25. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 [CD-ROM]. Hyattsville, MD: US Department of Health and Human Services, Public Health Service. Centers for Disease Control and Prevention, 1996.
26. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
27. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
28. Garg UC, Zheng ZJ, Folsom AR, et al. Short-term and long-term variability of plasma homocysteine measurement. Clin Chem 1997; 43:141-5.
29. Shah BV, Barnwell BG, Bieler GS, SUDAAN user's manual, release 7.0. Research Triangle Park, NC: Research Triangle Institute, 1996.
30. SAS Institute Inc. The SAS system for Windows, version 6.12. Cary, NC: SAS Institute Inc, 1996.
31. Chambers JB, Cleveland WS, Kleiner B, Tukey PA. Graphical methods for data analysis. Boston: Duxbury Press, 1983.
32. SPSS Inc. SYSTAT 7.0 for Windows. Chicago: SPSS Inc, 1997.
33. Vilaseca MA, Moyano D, Ferrer I, Artuch R. Total homocysteine in pediatric patients. Clin Chem 1997;43:690-1.
34. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996;64:587-93.
35. Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997;52:495-502.
36. Ubbink JB, Vermaak WJH, Bennett JM, Becker PJ, van Staden DA, Bissbort S. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr 1991;69:527-34.
37. Ubbink JB, Vermaak WJH, Delport R, van der Merwe A, Becker PJ, Potgieter H. Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr 1995; 62:802-8.
38. McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African Americans. Thromb Res 1996;83:195-8.
39. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
40. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.